Interoperable data systems can improve cancer care

Cancer centers today are facing growing pressure from stakeholders across the cancer care and research community to meet data-driven expectations. Yet many centers continue to rely on fragmented, siloed data systems that ...

Research: FDA drug labels not proof of patent violation

Federal law requires every prescription drug to include a document describing dosing guidelines, contraindications, results from clinical trials and safety considerations. But a spate of recent court decisions has problematically ...

page 34 from 40